C12N 2710/14145
Special targeting system for viral vectors
C12N2710/14145 (Special targeting system for viral vectors) appears on 6 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 6
- Assignees
- 14
- Inventors
- 18
- Latest grant
- 22 Oct 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Puma protein expression vector and use thereof in gene therapy22 Oct 2019US 10,449,232 B2Hospices Civils De Lyon
- Baculovirus-based vaccines31 Jan 2017US 9,555,091 B2Konkuk University Industrial Cooperation Corp.
- Baculoviruses with enhanced virion production and a method for the production of baculoviruses22 Apr 2014US 8,703,469 B2Boyce Thompson Institute for Plant Research, Inc.
- Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein15 Jan 2002US 6,338,953 B1
- Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein20 Feb 2001US 6,190,887 B1Biogen, Inc.
- Puma protein expression vector and use thereof in gene therapy25 Aug 2016US 2016/0243194 A1Hospices Civils De Lyon
- Baculovirus-based vaccines29 Jan 2015US 2015/0030621 A1Konkuk University Industrial Cooperation Corp.
- Baculoviruses with enhanced virion production and a method for the production of baculoviruses14 Mar 2013US 2013/0065296 A1Boyce Thompson Institute for Plant Research, Inc.
- Baculovirus-Based Vaccines11 Nov 2010US 2010/0285056 A1Konkuk University Industrial Cooperation Corp.
- Humanised Baculovirus28 May 2009US 2009/0136451 A1
Most cited
By later US patents
- Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein41US 6,338,953 B12002
- Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein18US 6,190,887 B1Biogen, Inc. · 2001
- Recombinant baculovirus with broad host range5US 5,639,454 ABoard of Trustees operating Michigan State University · 1997
- Baculovirus-based vaccines4US 9,555,091 B2Konkuk University Industrial Cooperation Corp. · 2017